JATT PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

JATT ▲ +7.35% at T+20d

NEUTRAL call ✓ call won +7.35% · α vs SPY +2.44% · entry $10.20 → $10.95

Next anchor: T+60d in 5w

Last close $10.48 (close Jun 8) · +2.75% from $10.20 entry

Entry anchored
Apr 20, 11:00 AM ET
via Databento tick

T+1d

+3.33%

call +3.33% · α +2.31%

$10.54

settled 7w ago

T+5d

+7.06%

call +7.06% · α +5.98%

$10.92

settled 6w ago

T+20d

+7.35%

call +7.35% · α +2.44%

$10.95

settled 23d ago

T+60d

—

call — · α —

—

in 5w

Price Chart

Loading chart...

Executive Summary

JATT II Acquisition Corp completed its IPO of 6 million shares at $10.00 per share, raising $60 million in gross proceeds. The SPAC, focused on healthcare and biotech targets, will begin trading on Nasdaq under 'JATT'. An additional 900,000 shares may be issued via a 45-day over-allotment option.

Key Financial Metrics

Deal Value

$60.0M

Actionable Insight

Monitor for future announcements on potential acquisition targets, particularly in biotech or computational biology. The over-allotment option could increase float by 15% — watch for underwriter activity in the next 45 days.

Key Facts

IPO closed on April 20, 2026, with 6,000,000 shares issued at $10.00 per share
Total gross proceeds: $60,000,000 (before underwriting discounts and expenses)
Shares began trading on Nasdaq under ticker 'JATT' on April 17, 2026
Underwriters granted 45-day option to purchase up to 900,000 additional shares
SPAC targets healthcare and life sciences, particularly data-driven biotech companies
Sponsored by JATT Ventures II L.P., led by Dr. Someit Sidhu (CEO) and Nicholas Fernandez (CFO)

Financial Impact

$60 million gross proceeds raised; potential for additional $9 million if over-allotment exercised

cashdilutionmarket_cap

Risk Factors

No identified target yet; risk of failure to complete a business combination within required timeframe
Proceeds may not be used as intended; future dilution possible in a de-SPAC transaction

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3277497

3 reports for JATT

T+1T+5T+20T+60

Filters

Reports for JATT — sortable, filterable
	Type				Now
Apr 24, 2026 6w ago	8-K NEUTRAL ★ 5/10	$10.94 $10.90	▼ −0.37%	▼ −5.32%	$10.48 (−4.20%)
Apr 20, 2026 7w ago	Press Release NEUTRAL ★ 5/10	$10.20 $10.95	▲ +7.35%	▲ +2.44%	$10.48 (+2.75%)
Apr 16, 2026 7w ago	Press Release NEUTRAL ★ 5/10	$10.50 $10.55	▲ +0.48%	▼ −4.89%	$10.48 (−0.19%)

US Market Status

Market Closed — Opens Thu (9h 37m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access